Dzuveo Európska únia - slovenčina - EMA (European Medicines Agency)

dzuveo

laboratoire aguettant - sufentanil citrát - bolesť - anestetiká - dzuveo is indicated for the management of acute moderate to severe pain in adult patients.

Prúžky testovacie TD-4335 Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

prúžky testovacie td-4335

taidoc technology corp. 6f, no. 127, wugong 2nd road 24888 wugu district, new taipei city taiwan -

Nolpaza 40 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nolpaza 40 mg

krka, d.d., novo mesto, slovinsko - pantoprazol - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

Everolimus Teva 10 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

everolimus teva 10 mg

teva pharmaceuticals slovakia s.r.o., slovensko - everolimus - 44 - cytostatica

Enhertu Európska únia - slovenčina - EMA (European Medicines Agency)

enhertu

daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplazmy prsníkov - antineoplastické činidlá - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.